Company Profile

Company Overview

Name SymBio Pharmaceuticals Limited
Address Toranomon 30 Mori Bldg., 3-2-2 Toranomon, Minato-ku, Tokyo 105-0001, Japan
Tel: +81-3-5472-1125 Fax: +81-3-5472-3054
For inquiry about brincidofovir: +81-3-6684-6663
Established March 25, 2005
Capital stock JPY17,548,459,551 (at the end of December 2022)
Board of Directors Fuminori Yoshida Representative Director
Shigetoshi Matsumoto Board Director <Outside>
Bruce David Cheson Board Director <Outside>
Eiji Ebinuma Board Director <Outside>
Kiyoshi Watanabe Board Director, Full-Time Audit & Supervisory Committee Member<Outside>
Kesao Endo Board Director, Audit & Supervisory Committee Member<Outside>
Yasuhiro Tamo Board Director, Audit & Supervisory Committee Member<Outside>
Corporate Officers Fuminori Yoshida Corporate Officer, President and Chief Executive Officer
Takaaki Fukushima Executive Corporate Officer, Chief Financial Officer
Koji Fukushima Corporate Officer, Chief Medical Officer
Yoshiharu Torikai Corporate Officer
Masahiko Okuno Corporate Officer
Hiroyuki Horita Corporate Officer
Subsidiary SymBio Pharma USA, Inc.
Durham, North Carolina, USA
Carolyn YanavichPresident and Chief Operating Officer